Clinical Infectious Diseases · 2021 · 205 citations · 25 references
Veterinary MedicineInfectious DiseasesPediatricsDisease SurveillancePediatric EpidemiologyPediatric Infectious DiseasesPulmonary InfectionsRespiratory DiseaseRespiratory Disease Epidemiology In ChildrenRespiratory InfectionsRespiratory Infectious DiseasesRespiratory Tract InfectionsChildhood Pneumonia EpidemiologyPneumococcal DiseaseProspective Cohort SurveillanceRespiratory Illness SurveillanceRespiratory Infections In ChildrenRespiratory VirusesSars-cov-2 InfectionSars-cov-2 Pneumonia
BACKGROUND: The incidence of invasive pneumococcal disease (IPD) declined during the COVID-19 pandemic. Previous studies hypothesized that this was due to reduced pneumococcal transmission resulting from nonpharmaceutical interventions. We used multiple ongoing cohort surveillance projects in children <5 years to test this hypothesis. METHODS: The first SARS-CoV-2 cases were detected in February 2020, resulting in a full lockdown, followed by several partial restrictions. Data from ongoing surveillance projects captured the incidence dynamics of community-acquired alveolar pneumonia (CAAP), nonalveolar lower respiratory infections necessitating chest X-rays (NA-LRIs), nasopharyngeal pneumococcal carriage in nonrespiratory visits, nasopharyngeal respiratory virus detection (by polymerase chain reaction), and nationwide IPD. Monthly rates (January 2020 through February 2021 vs mean monthly rates 2016-2019 [expected rates]) adjusted for age and ethnicity were compared. RESULTS: CAAP and bacteremic pneumococcal pneumonia were strongly reduced (incidence rate ratios [IRRs]: .07 and .19, respectively); NA-LRIs and nonpneumonia IPD were also reduced by a lesser magnitude (IRRs: .46 and .42, respectively). In contrast, pneumococcal carriage prevalence was only slightly reduced, and density of colonization and pneumococcal serotype distributions were similar to previous years. The decline in pneumococcus-associated disease was temporally associated with a full suppression of respiratory syncytial virus, influenza viruses, and human metapneumovirus, often implicated as co-pathogens with pneumococcus. In contrast, adenovirus, rhinovirus, and parainfluenza activities were within or above expected levels. CONCLUSIONS: Reductions in pneumococcal and pneumococcus-associated diseases occurring during the COVID-19 pandemic in Israel were not predominantly related to reduced pneumococcal carriage and density but were strongly associated with the disappearance of specific respiratory viruses.
25
R: A Language and Environment for Statistical Computing
R Core Team · 2000 · 353K citations · Full text
Natural Sciences, Computer Science, Statistical Computing +10
Angela B. Brueggemann, Melissa J. Jansen van Rensburg, David R. Shaw et al. · The Lancet Digital Health · 2021 · 539 citations · Full text
Clark D Russell, Cameron J Fairfield, Thomas M Drake et al. · The Lancet Microbe · 2021 · 334 citations · Full text
Pharmacy, Infectious Disease Control, Infectious Diseases +17
François Angoulvant, Naïm Ouldali, David Dawei Yang et al. · Clinical Infectious Diseases · 2020 · 322 citations · Full text